Cargando…
Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
Hepatocellular carcinoma (HCC) is a malignancy with a poor prognosis. Surgery combined with chemotherapy has been recommended as a curative regimen for HCC. Nevertheless, the anticancer mechanisms of chemicals in hepatocellular carcinoma remain unclear. Pyroptosis is a type of programmed necrosis, a...
Autores principales: | Hu, Jian, Dong, Yi, Ding, Li, Dong, Yang, Wu, Zhihua, Wang, Wenping, Shen, Ming, Duan, Yourong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799825/ https://www.ncbi.nlm.nih.gov/pubmed/31637008 http://dx.doi.org/10.1038/s41392-019-0062-9 |
Ejemplares similares
-
The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017) -
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
por: Kong, Degang, et al.
Publicado: (2020) -
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017) -
Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022) -
Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells
por: Alarifi, Saud, et al.
Publicado: (2013)